Schlenk, R. F.
Weber, D.
Herr, W.
Wulf, G.
Salih, H. R.
Derigs, H. G.
Kuendgen, A.
Ringhoffer, M.
Hertenstein, B.
Martens, U. M.
Grießhammer, M.
Bernhard, H.
Krauter, J.
Girschikofsky, M.
Wolf, D.
Lange, E.
Westermann, J.
Koller, E.
Kremers, S.
Wattad, M.
Heuser, M.
Thol, F.
Göhring, G.
Haase, D.
Teleanu, V.
Gaidzik, V.
Benner, A.
Döhner, K.
Ganser, A.
Paschka, P.
Döhner, H.
Funding for this research was provided by:
This work was supported by an unrestricted grant and supply of study drug (azacitidine) from Celgene GmbH.
Article History
Received: 2 December 2018
Revised: 4 January 2019
Accepted: 11 January 2019
First Online: 6 February 2019
Compliance with ethical standards
:
: KD, AK, JW and HD received research funding from Celgene; KD, HD, JW, PP received speakers honoraria from Celgene; KD, PP, JW, AG and HD participated in Celgene Advisory Boards. The other authors declare that they have no conflict of interest.